Page last updated: 2024-10-21

zopolrestat and Non-alcoholic Fatty Liver Disease

zopolrestat has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies

zopolrestat: structure given in first source

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, T1
Shi, D1
Chen, J1
Yang, Y1
Qiu, M1
Wang, W1
Qiu, L2
Lin, J1
Xu, F1
Gao, Y1
Zhang, C1
Liu, Y1
Luo, Y1
Yang, JY1

Other Studies

2 other studies available for zopolrestat and Non-alcoholic Fatty Liver Disease

ArticleYear
Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor α.
    Molecular medicine reports, 2015, Volume: 11, Issue:1

    Topics: Aldehyde Reductase; Animals; Benzothiazoles; Diet; Disease Models, Animal; Enzyme Activation; Enzyme

2015
Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice.
    Experimental diabetes research, 2012, Volume: 2012

    Topics: Aldehyde Reductase; Animals; Benzothiazoles; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme In

2012